We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-22.98%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$106M
AUM Growth
-$42.2M
Cap. Flow
-$5.48M
Cap. Flow %
-5.17%
Top 10 Hldgs %
100%
Holding
7
New
Increased
1
Reduced
2
Closed

Top Buys

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$3.12M

Top Sells

Rank Stock Value
1
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.32M
2
NTRA icon
Natera
NTRA
+$4.28M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$35.3M 33.31%
797,436
-84,000
-10% -$4.28M
AKYA
2
DELISTED
Akoya BioSciences
AKYA
$21.8M 20.62%
4,697,785
GH icon
3
Guardant Health
GH
$21.9B
$20M 18.92%
676,047
ADPT icon
4
Adaptive Biotechnologies
ADPT
$4.07B
$13M 12.23%
2,377,665
-652,769
-22% -$4.32M
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
$6.45M 6.09%
3,751,891
+1,025,000
+38% +$3.12M
MXCT icon
6
MaxCyte
MXCT
$143M
$5.88M 5.55%
1,885,000
SONX
7
DELISTED
Sonendo, Inc.
SONX
$3.46M 3.27%
4,643,461

Similar funds

Blue Water Life Science Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Blue Water Life Science Advisors held 7 positions worth $106M, down 29% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $5.48M in Q3 2023, reducing 2 holdings. Its largest reduction was Adaptive Biotechnologies, cutting an estimated $4.32M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors added an estimated $3.12M to NanoString Technologies, Inc..

  • Blue Water Life Science Advisors added most to NanoString Technologies, Inc. in Q3 2023, an estimated $3.12M increase.
  • Blue Water Life Science Advisors's biggest Q3 2023 reduction was Adaptive Biotechnologies, cutting an estimated $4.32M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $106M portfolio in Q3 2023.
  • Blue Water Life Science Advisors opened 0 new positions and closed 0 in Q3 2023.
  • Blue Water Life Science Advisors's portfolio value fell 29% quarter-over-quarter to $106M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.